These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32894391)

  • 1. Ocular microcirculation changes, measured with laser speckle flowgraphy and optical coherence tomography angiography, in branch retinal vein occlusion with macular edema treated by ranibizumab.
    Asano T; Kunikata H; Yasuda M; Nishiguchi KM; Abe T; Nakazawa T
    Int Ophthalmol; 2021 Jan; 41(1):151-162. PubMed ID: 32894391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in Ocular Blood Flow after Ranibizumab Intravitreal Injection for Diabetic Macular Edema Measured Using Laser Speckle Flowgraphy.
    Toto L; Evangelista F; Viggiano P; Erroi E; D'Onofrio G; Libertini D; Porreca A; D'Aloisio R; Mariacristina P; Di Antonio L; Di Nicola M; Mastropasqua R
    Biomed Res Int; 2020; 2020():9496242. PubMed ID: 32104710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between optic nerve head circulation and visual function before and after anti-VEGF therapy for central retinal vein occlusion: prospective, interventional case series.
    Nagasato D; Mitamura Y; Semba K; Akaiwa K; Nagasawa T; Yoshizumi Y; Tabuchi H; Kiuchi Y
    BMC Ophthalmol; 2016 Apr; 16():36. PubMed ID: 27044276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macular vessel reduction as predictor for recurrence of macular oedema requiring repeat intravitreal ranibizumab injection in eyes with branch retinal vein occlusion.
    Hasegawa T; Takahashi Y; Maruko I; Kogure A; Iida T
    Br J Ophthalmol; 2019 Oct; 103(10):1367-1372. PubMed ID: 30514711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Retinal Microcirculation After Intravitreal Ranibizumab Injection in Eyes With Macular Edema Secondary to Branch Retinal Vein Occlusion.
    Fukami M; Iwase T; Yamamoto K; Kaneko H; Yasuda S; Terasaki H
    Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):1246-1255. PubMed ID: 28241312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COMBINATION THERAPY OF INTRAVITREAL RANIBIZUMAB AND SUBTHRESHOLD MICROPULSE PHOTOCOAGULATION FOR MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION: 6-MONTH RESULT.
    Terashima H; Hasebe H; Okamoto F; Matsuoka N; Sato Y; Fukuchi T
    Retina; 2019 Jul; 39(7):1377-1384. PubMed ID: 29689025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macular function following intravitreal ranibizumab for macular edema associated with branch retinal vein occlusion.
    Nishimura T; Machida S; Tada A; Oshida E; Muto T
    Doc Ophthalmol; 2019 Aug; 139(1):67-74. PubMed ID: 30980231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macular function following intravitreal ranibizumab for macular edema associated with branch retinal vein occlusion: 12-month results.
    Nishimura T; Machida S; Tada A; Oshida E; Muto T
    Doc Ophthalmol; 2020 Oct; 141(2):127-136. PubMed ID: 32100140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between short- and long-term effects of intravitreal ranibizumab therapy on macular edema after branch retinal vein occlusion: a prospective observational study.
    Minami Y; Nagaoka T; Ishibazawa A; Yoshida A
    BMC Ophthalmol; 2017 Jun; 17(1):90. PubMed ID: 28610573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twenty-Four Month Results of Intravitreal Ranibizumab for Macular Edema after Branch Retinal Vein Occlusion: Visual Outcomes and Resolution of Macular Edema.
    Inagaki M; Hirano Y; Yasuda Y; Kawamura M; Suzuki N; Yasukawa T; Yoshida M; Ogura Y
    Semin Ophthalmol; 2021 Oct; 36(7):482-489. PubMed ID: 33617388
    [No Abstract]   [Full Text] [Related]  

  • 11. Real-life clinical data for dexamethasone and ranibizumab in the treatment of branch or central retinal vein occlusion over a period of six months.
    Winterhalter S; Eckert A; Vom Brocke GA; Schneider A; Pohlmann D; Pilger D; Joussen AM; Rehak M; Grittner U
    Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):267-279. PubMed ID: 29185099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Retinal Microvasculature and Visual Acuity After Antivascular Endothelial Growth Factor Therapy in Retinal Vein Occlusion.
    Winegarner A; Wakabayashi T; Fukushima Y; Sato T; Hara-Ueno C; Busch C; Nishiyama I; Shiraki N; Sayanagi K; Nishida K; Sakaguchi H; Nishida K
    Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):2708-2716. PubMed ID: 29860457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OPTICAL COHERENCE TOMOGRAPHY PREDICTORS OF SHORT-TERM VISUAL ACUITY IN EYES WITH MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION TREATED WITH INTRAVITREAL CONBERCEPT.
    Tang F; Qin X; Lu J; Song P; Li M; Ma X
    Retina; 2020 Apr; 40(4):773-785. PubMed ID: 30640282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodal imaging to distinguish microvascular and morphological changes in retinal vein occlusion after intravitreal ranibizumab with or without triamcinolone acetonide injection.
    Wang N; Zou J; Li S; Deng X; Zeng J; Ding C
    BMC Ophthalmol; 2024 Aug; 24(1):354. PubMed ID: 39164640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intravitreal ranibizumab on the ocular circulation of the untreated fellow eye.
    Sugimoto M; Nunome T; Sakamoto R; Kobayashi M; Kondo M
    Graefes Arch Clin Exp Ophthalmol; 2017 Aug; 255(8):1543-1550. PubMed ID: 28656342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Choroidal Thickness, Foveal Avascular Zone, and Macular Capillary Density in Macular Edema Secondary to Branch Retinal Vein Occlusion Treated with Ranibizumab or Aflibercept-A Prospective Study.
    Huang YT; Wang I; Lin CJ; Lai CT; Hsia NY; Chen HS; Tien PT; Bair H; Lin JM; Chen WL; Chen CH; Wu WC; Tsai YY
    Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal Blood Flow as a Predictor of Recurrence of Macular Edema after Intravitreal Ranibizumab Injection in Central Retinal Vein Occlusion.
    Takano Y; Noma H; Yasuda K; Yamaguchi T; Goto H; Shimura M
    Ophthalmic Res; 2021; 64(6):1013-1019. PubMed ID: 34461615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of clinical efficacy of intravitreal ranibizumab with and without triamcinolone acetonide in macular edema secondary to central retinal vein occlusion.
    Fan C; Wang Y; Ji Q; Zhao B; Xie J
    Curr Eye Res; 2014 Sep; 39(9):938-43. PubMed ID: 24635755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of "treat and monitor" regimen of aflibercept and ranibizumab in macular edema secondary to non-ischemic branch retinal vein occlusion.
    Pichi F; Elbarky AM; Elhamaky TR
    Int Ophthalmol; 2019 Jan; 39(1):145-153. PubMed ID: 29274022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between ranibizumab and aflibercept for macular edema associated with central retinal vein occlusion.
    Saishin Y; Ito Y; Fujikawa M; Sawada T; Ohji M
    Jpn J Ophthalmol; 2017 Jan; 61(1):67-73. PubMed ID: 27660163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.